Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
356.3. Opportunities

Chapter: 4 GLOBAL PROFESSIONAL DIAGNOSTICS MARKET, BY TYPE 

4.1. OVERVIEW 

4.1.1. Market size and forecast

4.2. IMMUNOCHEMISTRY 

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. CLINICAL MICROBIOLOGY 

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.5. POINT OF CARE TEST (POC) 

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. HEMATOLOGY 

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. HEMOSTASIS 

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

Chapter: 5 GLOBAL PROFESSIONAL DIAGNOSTICS MARKET, BY END USERS 

5.1. OVERVIEW

4.1.1. Market size and forecast

5.2. HOSPITALS 

5.2.1. Key market trends
5.2.2. Growth factors and opportunities
5.2.3. Market size and forecast

5.3. DIAGNOSTIC LABORATORIES 

5.3.1. Key market trends
5.3.2. Growth factors and opportunities
 5.3.3. Market Size And Forecast 

5.4. OTHERS 

5.4.1. Key market trends
5.4.2. Growth factors and opportunities
 5.4.3. Market Size And Forecast 

Chapter: 6 GLOBAL PROFESSIONAL DIAGNOSTICS MARKET, BY REGION

6.1. OVERVIEW
6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast

6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast

6.2.4. North America Professional Diagnostics Market by Type 
6.2.5. North America Professional Diagnostics Market by End Users

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast

6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast

6.3.5. Europe Professional Diagnostics Market by Types 
6.3.4. Europe Professional Diagnostics Market by End Users

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast

6.4.3.1. Japan market size and forecast
6.4.2.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. Rest of Asia-Pacific market size and forecast

6.4.4. Asia-Pacific Professional Diagnostics Market by Types 
6.4.5. Asia-Pacific Professional Diagnostics Market by End Users

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast

6.5.3.1. Brazil market size and forecast
6.5.3.2. Turkey market size and forecast
6.5.3.3. Argentina market size and forecast
6.5.3.4. South Africa market size and forecast
6.5.3.5. Rest of LAMEA market size and forecast

6.5.4. LAMEA Professional Diagnostics Market by Types 
6.5.5. LAMEA Professional Diagnostics Market by End Users

Chapter: 7 COMPANY PROFILES

7.1. ABBOTT LABORATORIES

7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments

7.2. SIEMENS MEDICAL SOLUTIONS USA, INC.

7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.3. F. HOFFMANN LA ROCHE LTD

 7.3.1. Operating Business Segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments

7.4. THERMOFISCHER SCIENTIFIC INC.

7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments

7.5. ABAXIS

7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments

7.7. HOLOGIC INC.

7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments

7.7. BIO-RAD LABORATORIES INC

7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments

7.8. ALERE

7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments

7.9. ENZO BIOCHEM INC.

7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments

7.10. BECTON, DICKENSON AND COMPANY (BD)

7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments